Yahoo Finance

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

inFoods ® IBS provides personalized identification of food triggers to substantially improve IBS-related symptoms like bloating, abdominal pain, diarrhea, and constipation IRVINE, Calif., July 02, ...
Yahoo Finance

BMRA: More Positive Clarity on InFoods' FDA Pathway

FDA Determines InFoods is ‘Nonsignificant Risk’ Device: Eliminates Need for IDE Approval, Supports Expectation of De Novo Pathway… Yesterday (July 11) Biomerica (BMRA) announced that the FDA has ...
Seeking Alpha

inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology

Gastro Health, a leading gastroenterology group, plans to utilize this simplified blood collection method when recommending the inFoods ® IBS to their patients Biomerica (BMRA) also announced that ...
Nasdaq

Biomerica's InFoods® Irritable Bowel Syndrome Diagnostic-Guided Therapy Clinical Trial Nears Completion of Enrollment

IRVINE, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced it is nearing completion of patient enrollment in the ...
Nasdaq

Biomerica’s inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

IRVINE, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic products, is pleased to announce that inFoods® IBS, ...
Yahoo Finance

Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

Study results suggest inFoods IBS could be particularly beneficial for IBS-M patients, a population with no current FDA-approved drug treatments. The randomized, multicenter, double-blind, ...
manilatimes

Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026

Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world’s largest GI medical conference, May 2-5, 2026, in Chicago DDW is the world’s largest ...
Taiwan News

Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

inFoods IBS Provides Personalized Diet Therapy for Patients Suffering with Irritable Bowel Syndrome (IBS) Research Finds Patients Following a Personalized Diet Therapy Created with inFoods ® IBS, ...
Hosted on MSN

Biomerica announces inFoods IBS product featured in Biotherapeutics Quarterly

Biomerica (BMRA) announced that its inFoods IBS diagnostic-guided therapy product is being featured in the Fall 2025 issue of Biotherapeutics Quarterly. The article, titled “Precision Medicine for IBS ...
manilatimes

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

PLA Code issuance by the American Medical Association CPT editorial panel marks a meaningful step toward attaining health insurance reimbursement and expanded patient access for inFoods® IBS inFoods® ...
Finanznachrichten

Biomerica, Inc.: Biomerica's inFoods IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

The inFoods ® IBS test was designed specifically for IBS patients. It identifies individual foods that trigger an elevated (above normal) Immunoglobulin G (IgG) antibody responses-which is a marker of ...